Skip to main content
. 2019 Nov 10;25:8472–8481. doi: 10.12659/MSM.918252

Figure 4.

Figure 4

(A, B) AB23A attenuates the lipopolysaccharide (LPS)-induced alteration in TLR4/NOX2 signaling. The western blotting assay showed the pre-treatment of AB23A to reduce the increasing expressions of TLR4, NOX2, p-P38, and p-ERK protein in LPS-induced septic mice (n=3).